Glp Bioanalysis Target Invitrox as a reliable GLP-compliant bioanalytical partner for nonclinical and clinical programs, highlighting their LC-MS/MS, immunoassays, and DMPK capabilities to support discovery, lead optimization, and PK/PD modeling.

Full Service Position their integrated offerings from discovery bioanalysis through preclinical PK, metabolite profiling, biomarkers, and therapeutic drug monitoring as a one-stop solution for biotech and pharma programs seeking streamlined timelines and compliant data generation.

Small Cap Advantage Leverage Invitrox’s agile scale (11-50 employees) and nimble operations to win collaborations with mid-market biotech firms needing personalized attention, flexible study design, and faster decision cycles compared to larger CROs.

Advanced Tech Emphasize state-of-the-art instrumentation and diverse analytical capabilities (UPLC/HPLC-MS, GC, FT-IR, plate readers) to handle complex matrices and broad assay requirements, aligning with clients’ need for robust and versatile analytical support.

Regional Focus Capitalize on proximity to RTP/Durham with targeted outreach to nearby biotech clusters and universities, offering local collaboration opportunities, quick startup of studies, and convenient logistics for sample handling and data reporting.